Patents Examined by Izabela Schmidt
  • Urea compounds and compositions as SMARCA2/BRM ATPase inhibitors
    Patent number: 11958846
    Abstract: A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a BRM-mediated and/or BRG1-mediated disease or disorder: Formula (I) wherein R1 through R6 are as defined herein.
    Type: Grant
    Filed: August 12, 2019
    Date of Patent: April 16, 2024
    Assignee: Novartis AG
    Inventors: Christopher Adair, Katsumasa Nakajima, Rukundo Ntaganda, Julien Papillon, Troy Douglas Smith